Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application

Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application

Item
http://www.wikidata.org/entity/Q28079309
Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis.MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis.FGFR inhibitor, AZD4547, impedes the stemness of mammary epithelial cells in the premalignant tissues of MMTV-ErbB2 transgenic miceTherapy for Cancer: Strategy of Combining Anti-Angiogenic and Target Therapies.Inhibitor repurposing reveals ALK, LTK, FGFR, RET and TRK kinases as the targets of AZD1480.ERα Binding by Transcription Factors NFIB and YBX1 Enables FGFR2 Signaling to Modulate Estrogen Responsiveness in Breast Cancer.An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers.Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors.Discovery and Biological Evaluation of a Series of Pyrrolo[2,3-b]pyrazines as Novel FGFR Inhibitors.Targeting the tumour stroma to improve cancer therapy.Resistance to Anti-Angiogenic Therapy in Cancer-Alterations to Anti-VEGF Pathway.Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT/PDGFRA genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western Greece.Gamma-Klotho exhibits multiple roles in tumor growth of human bladder cancer.Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions.Specific Antibody Fragment Ligand Traps Blocking FGF1 ActivityFGFR3 mRNA overexpression defines a subset of oligometastatic colorectal cancers with worse prognosisFGFR1/FOXM1 pathway: a key regulator of glioblastoma stem cells radioresistance and a prognosis biomarker
P2860

Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application

Item
http://www.wikidata.org/entity/Q28079309
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Inhibition of the fibroblast g ...... rriers to clinical application
@ast
Inhibition of the fibroblast g ...... rriers to clinical application
@en
Inhibition of the fibroblast g ...... rriers to clinical application
@nl
type
label
Inhibition of the fibroblast g ...... rriers to clinical application
@ast
Inhibition of the fibroblast g ...... rriers to clinical application
@en
Inhibition of the fibroblast g ...... rriers to clinical application
@nl
prefLabel
Inhibition of the fibroblast g ...... rriers to clinical application
@ast
Inhibition of the fibroblast g ...... rriers to clinical application
@en
Inhibition of the fibroblast g ...... rriers to clinical application
@nl
P1433
P1476
P2093
P275
P2860
P31
P356
P407
P577
P698
P921
P932
P356
P1433
P1476
Inhibition of the fibroblast g ...... rriers to clinical application
@en
P2093
P275
P2860
P31
P356
P407
P577
P698
P921
P932